Cancer

Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…

Liquid biopsies have transformed cancer diagnostics by offering a minimally invasive method to analyze tumor-derived materials circulating in biological fluids. This approach provides critical insights for cancer detection, therapy selection, and disease monitoring, complementing or replacing traditional tissue biopsies and imaging techniques that often carry procedural risks and limitations.

Kalorama Information’s The Worldwide Market for…

The next era of healthcare is here—and it’s powered by companion diagnostics (CDx). These essential tools are redefining how diseases are detected, monitored, and treated by aligning diagnostics directly with therapeutic decision-making. Kalorama Information’s Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition provides an in-depth, data-driven analysis of this rapidly evolving market—one…

Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address…

Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.

Worldwide Market for Point-of-Care…